| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| AL_RIC - Bandi da altri enti di ricerca |
Validazione di due nuovi trattamenti per la sindrome di Rett: focus sui difetti respiratori della malattia
|
|
Ongoing | 2022 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Fluoxetine reveres cognitive defects in a mouse model of AT: a preclinical study to elucidate the precise mechanism of action
|
|
Ongoing | 2022 |
| DECC - Bando Dipartimenti di Eccellenza |
Assegnazione Dipartimenti di Eccellenza 2023-2027 - Dipartimento di BIOTECNOLOGIE MEDICHE E MEDICINA TRASLAZIONALE
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
The interplay between HPCAL4 and MeCP2: identification and characterization of a novel putative target for Rett syndrome therapy
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
The natural antisense lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
Identification of molecular immune-metabolic profiles in pancreatic cancer to advance management of pancreatic diseases (3° anno)
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
Functional study on a new pharmacological approach in the Rett Syndrome
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
All-optical fingerprinting of metastatic potential (5° anno)
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
Evidence-based approach to treat hyperexcitability in Rett syndrome though splicing modulation
|
|
Ongoing | 2021 |
| Horizon Europe Global Challenge-RIA/IA/CSA |
The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV
|
|
Ongoing | 2022 |
